News

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
India is seeing a rise in COVID-19 cases, with 6,133 active infections as per the Health Ministry on June 8, 2025. The surge ...
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
United Therapeutics Corp. (UTC) and Liquidia Technologies Inc. have been battling for close to a decade over their respective inhaled formulations ...
In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, ...
Edaran Tan Chong Motor (ETCM) has announced the opening of its new Nissan showroom located in Kluang, Johor, expanding its ...
In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.
A Hundred Experts Urge Strengthening Early Diagnosis of Pulmonary Hypertension in Latin America ...
Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...
Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...
Keros will be down to 85 full-time employees after the layoffs and expects to generate annualized savings of $17 million.
Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...